Page 1,584«..1020..1,5831,5841,5851,586..1,5901,600..»

Plandai Biotechnology Names Ezra Jones as Vice President of … – Yahoo Finance

Posted: April 29, 2017 at 3:42 am

LONDON, UNITED KINGDOM--(Marketwired - Apr 28, 2017) - Planda Biotechnology, Inc. ( OTC PINK : PLPL ) ("Planda" or "the Company"), producer of the highly bioavailable Phytofare catechin complex, today announced that Ezra Jones has been appointed Vice President of Sales and Marketing, a role he assumes from Callum Cottrell-Duffield, who was recently named Chief Operating Officer of Planda.

Mr. Jones has been involved in sales of nutraceutical branded ingredients for the past 18 years. He was he was with NutraGenesis for 3.5 years, and has recently, before Planda, been working as an independent sales representative for numerous worldwide companies.Since 2016, Mr. Jones has overseen all North American sales efforts for Planda.As the new head of sales and marketing, his responsibilities will expand to overseeing all global sales efforts, working with the company's independent sales reps and distributors, building additional sales channels, and growing the Phytofare brand.

Callum Cottrell-Duffield, President of Planda, commented, "Having worked with Ezra for the past year, I have been impressed with his passion for the product and knowledge of the industry.He has been instrumental in opening our largest accounts and is a driven salesman.As we now expand into a global brand and introduce new products in the coming year, Ezra's experience in building and training a sales force will be invaluable."

About Planda Biotechnology, Inc.

Planda Biotechnology, Inc. and its subsidiaries develop highly phyto-available extracts. Planda Biotechnology controls every aspect of the process, from growing green tea on its farms in South Africa, to producing its proprietary Phytofare extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include beverage, cosmeceutical, wellness, nutriceutical, anti-aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com.

Safe Harbor Statement

This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities and Exchange Commission that can be accessed over the Internet at the SEC's website located at http://www.sec.gov.

Here is the original post:
Plandai Biotechnology Names Ezra Jones as Vice President of ... - Yahoo Finance

Posted in Biotechnology | Comments Off on Plandai Biotechnology Names Ezra Jones as Vice President of … – Yahoo Finance

Unusual Activity Spotted in Cellect Biotechnology Ltd (APOPW) – Rockville Register

Posted: April 29, 2017 at 3:42 am

Needle moving action has been spotted in Cellect Biotechnology Ltd (APOPW) as shares are moving today onvolatility12.61% or $0.29 from the open.TheNASDAQ listed companysaw a recent bid of2.59 and49481shares have traded hands in the session.

Now letstake a look at how the fundamentals are stacking up for Cellect Biotechnology Ltd (APOPW). Fundamental analysis takes into consideration market, industry and stock conditions to help determine if the shares are correctly valued. Cellect Biotechnology Ltd currently has a yearly EPS of -0.14. This number is derived from the total net income divided by shares outstanding. In other words, EPS reveals how profitable a company is on a share owner basis.

Another key indicator that can help investors determine if a stock might be a quality investment is the Return on Equity or ROE. Cellect Biotechnology Ltd (APOPW) currently has Return on Equity of -86.72. ROE is a ratio that measures profits generated from the investments received from shareholders. In other words, the ratio reveals how effective the firm is at turning shareholder investment into company profits. A company with high ROE typically reflects well on management and how well a company is run at a high level. A firm with a lower ROE might encourage potential investors to dig further to see why profits arent being generated from shareholder money.

Another ratio we can look at is the Return on Invested Capital or more commonly referred to as ROIC. Cellect Biotechnology Ltd (APOPW) has a current ROIC of -86.72. ROIC is calculated by dividing Net Income Dividends by Total Capital Invested.

Similar to ROE, ROIC measures how effectively company management is using invested capital to generate company income. A high ROIC number typically reflects positively on company management while a low number typically reflects the opposite.

Turning to Return on Assets or ROA, Cellect Biotechnology Ltd (APOPW) has a current ROA of -74.92. This is a profitability ratio that measures net income generated from total company assets during a given period. This ratio reveals how quick a company can turn its assets into profits. In other words, the ratio provides insight into the profitability of a firms assets. The ratio is calculated by dividing total net income by the average total assets. A higher ROA compared to peers in the same industry, would suggest that company management is able to effectively generate profits from their assets. Similar to the other ratios, a lower number might raise red flags about managements ability when compared to other companies in a similar sector.

By

More:
Unusual Activity Spotted in Cellect Biotechnology Ltd (APOPW) - Rockville Register

Posted in Biotechnology | Comments Off on Unusual Activity Spotted in Cellect Biotechnology Ltd (APOPW) – Rockville Register

CRISPR-SMART Cells Regenerate Cartilage, Secrete Anti-Arthritis Drug – Genetic Engineering & Biotechnology News

Posted: April 29, 2017 at 3:41 am

We have anti-arthritis drugs. What we lack is the ability to deploy them when and where they are needed in the body. The drugs would be far more effective, and occasion fewer side effects, if they were to appear only in response to inflammation, and only in the joints. If the drugs could be delivered so painstakinglyso smartlythey wouldnt have to be administered systemically.

Although conventional drug delivery systems may be unable to respond to arthritic flares with such adroitness, cells may have better luckif they are suitably modified. Stem cells, for example, have been rewired by means of gene-editing technology to fight arthritis. These stem cells, known as SMART cells (Stem cells Modified for Autonomous Regenerative Therapy), develop into cartilage cells that produce a biologic anti-inflammatory drug. Ideally, the new cartilage cells will replace arthritic cartilage, and the biologic will protect against chronic inflammation, preserving joints and other tissues.

SMART cells of this sort were prepared by scientists based at Washington University School of Medicine in St. Louis. The scientists initially worked with skin cells taken from the tails of mice and converted those cells into stem cells. Then, using the gene-editing tool CRISPR in cells grown in culture, they removed a key gene in the inflammatory process and replaced it with a gene that releases a biologic drug that combats inflammation.

Details of this work appeared April 27 in the journal Stem Cell Reports, in an article entitled Genome Engineering of Stem Cells for Autonomously Regulated, Closed-Loop Delivery of Biologic Drugs. The article describes how modified stem cells grew into cartilage and produced cartilage tissue. The engineered cartilage, the scientists reported, was protected from inflammation.

Using the CRISPR/Cas9 genome-engineering system, we created stem cells that antagonize IL-1- [interleukin-1] or TNF-- [tumor necrosis factor-] mediated inflammation in an autoregulated, feedback-controlled manner, wrote the authors of the Stem Cell Reports article. Our results show that genome engineering can be used successfully to rewire endogenous cell circuits to allow for prescribed input/output relationships between inflammatory mediators and their antagonists, providing a foundation for cell-based drug delivery or cell-based vaccines via a rapidly responsive, autoregulated system.

Many current drugs used to treat arthritisincluding Enbrel (etanercept), Humira (adalimumab), and Remicade (infliximab)attack TNF-, an inflammation-promoting molecule. But the problem with these drugs is that they are given systemically rather than targeted to joints. As a result, they interfere with the immune system throughout the body and can make patients susceptible to side effects such as infections.

"We want to use our gene-editing technology as a way to deliver targeted therapy in response to localized inflammation in a joint, as opposed to current drug therapies that can interfere with the inflammatory response through the entire body," said Farshid Guilak, Ph.D., the paper's senior author and a professor of orthopedic surgery at Washington University School of Medicine. "If this strategy proves to be successful, the engineered cells only would block inflammation when inflammatory signals are released, such as during an arthritic flare in that joint."

Dr. Guilak's team encoded the stem/cartilage cells with genes that made the cells light up when responding to inflammation, so the scientists easily could determine when the cells were responding. Recently, the team began testing the engineered stem cells in mouse models of rheumatoid arthritis and other inflammatory diseases.

If the work can be replicated in animals and then developed into a clinical therapy, the engineered cells or cartilage grown from stem cells would respond to inflammation by releasing a biologic drugthe TNF- inhibitorthat would protect the synthetic cartilage cells that Dr. Guilak's team created and the natural cartilage cells in specific joints.

"When these cells see TNF-, they rapidly activate a therapy that reduces inflammation," Dr. Guilak explained. "We believe this strategy also may work for other systems that depend on a feedback loop. In diabetes, for example, it's possible we could make stem cells that would sense glucose and turn on insulin in response. We are using pluripotent stem cells, so we can make them into any cell type, and with CRISPR, we can remove or insert genes that have the potential to treat many types of disorders."

Excerpt from:
CRISPR-SMART Cells Regenerate Cartilage, Secrete Anti-Arthritis Drug - Genetic Engineering & Biotechnology News

Posted in Cell Medicine | Comments Off on CRISPR-SMART Cells Regenerate Cartilage, Secrete Anti-Arthritis Drug – Genetic Engineering & Biotechnology News

New study reveals how embryonic cells make spinal cord, muscle and bone – Medical Xpress

Posted: April 29, 2017 at 3:41 am

April 28, 2017 Neurons (red) and muscle cells (green) produced from NMPs in the laboratory. Credit: James Briscoe, Francis Crick Institute

A study from scientists at the Francis Crick Institute, the Max-Delbrck Center for Molecular Medicine, Berlin and the University of Edinburgh sheds new light on the cells that form spinal cord, muscle and bone tissue in mammalian embryos.

This discovery paves the way for generating these tissues from stem cells in the laboratory and could lead to new ways of studying degenerative conditions such as motor neuron disease and muscular dystrophy.

In embryos, the spinal cord, muscle and skeleton are produced from a group of cells called NMPs (neuro-mesodermal progenitors). These cells are few in number and exist only for a short time in embryos, despite giving rise to many tissues in the body. Their scarcity and inaccessibility has made studying NMPs challenging. Now, by using the latest molecular techniques, the research team has for the first time deciphered gene activity in NMPs. They used an advanced technique called single-cell transcriptional profiling, which analyses individual cells to provide a detailed picture of gene activity in every cell.

The technique allowed the team to establish a molecular signature of NMPs and to show that NMPs produced from stem cells in petri dishes in the laboratory closely resemble those found in embryos. This enabled the team to use lab-grown NMPs to learn more about these cells and how they make spinal cord, muscle and bone tissue. By manipulating the cells in petri dishes and testing the function of specific genes, the researchers re-constructed the regulatory mechanism and formulated a mathematical model that explains how NMPs produce the appropriate amounts of spinal cord and musculoskeletal cells.

Dr James Briscoe, who led the research from the Francis Crick Institute said:

"For embryonic development to progress smoothly, NMPs must make the right types of cells, in the right numbers at the right time. Understanding how cells such as NMPs make decisions is therefore central to understanding embryonic development. Single cell profiling techniques, including the ones we used in this study, are giving us unprecedented insight into this problem and offering a new and fascinating view of how embryos produce the different tissues that make up adults."

First author of the study Dr Mina Gouti, from the Max-Delbrck Center for Molecular Medicine, Berlin said:

"Improving our understanding of NMPs doesn't only answer an important developmental biology question but also holds great promise for regenerative medicine. It takes us a step closer to being able to use tissue from patients with diseases that affect muscles and motor neurons in order to study the causes and progress of these diseases. Being able to grow cells in the laboratory that faithfully resemble those found in the body is crucial for this."

The paper, A gene regulatory network balances neural and mesoderm specification during vertebrate trunk development, is published in Developmental Cell.

Explore further: Researchers turn stem cells into somites, precursors to skeletal muscle, cartilage and bone

More information: Mina Gouti et al. A Gene Regulatory Network Balances Neural and Mesoderm Specification during Vertebrate Trunk Development, Developmental Cell (2017). DOI: 10.1016/j.devcel.2017.04.002

Adding just the right mixture of signaling moleculesproteins involved in developmentto human stem cells can coax them to resemble somites, which are groups of cells that give rise to skeletal muscles, bones, and cartilage ...

Researchers at the University of Maine MicroInstruments and Systems Laboratory (MISL), in collaboration with The Jackson Laboratory, have developed a new microfluidic tool that reproduces in the laboratory the same physiochemical ...

Cedars-Sinai scientists are seeking to build an improved stem-cell model of amyotrophic lateral sclerosis (ALS) to accelerate progress toward a cure for the devastating neurological disorder. Their findings demonstrate that ...

esearchers from Hokkaido University in Japan together with an international team of scientists implanted specialized embryonic stem cells into the severed spinal cords of rats. The stem cells, called neural progenitor cells, ...

Caltech scientists have converted cells of the lower-body region into facial tissue that makes cartilage, in new experiments using bird embryos. The researchers discovered a "gene circuit," composed of just three genes, that ...

New research has unravelled the mystery of how mitochondriathe energy generators within cellscan withstand attacks on their DNA from rogue molecules.

A study from scientists at the Francis Crick Institute, the Max-Delbrck Center for Molecular Medicine, Berlin and the University of Edinburgh sheds new light on the cells that form spinal cord, muscle and bone tissue in ...

A gene previously identified as critical for tumor growth in many human cancers also maintains intestinal stem cells and encourages the growth of cells that support them, according to results of a study led by Johns Hopkins ...

A team of researchers at Sahlgrenska Academy has managed to generate cartilage tissue by printing stem cells using a 3-D-bioprinter. The fact that the stem cells survived being printed in this manner is a success in itself. ...

Using new gene-editing technology, researchers have rewired mouse stem cells to fight inflammation caused by arthritis and other chronic conditions. Such stem cells, known as SMART cells (Stem cells Modified for Autonomous ...

Researchers hope to one day use stem cells to heal burns, patch damaged heart tissue, even grow kidneys and other transplantable organs from scratch. This dream edges closer to reality every year, but one of the enduring ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Read the rest here:
New study reveals how embryonic cells make spinal cord, muscle and bone - Medical Xpress

Posted in Cell Medicine | Comments Off on New study reveals how embryonic cells make spinal cord, muscle and bone – Medical Xpress

Cyclist turns a death sentence into a race against diabetes – CNN

Posted: April 29, 2017 at 3:40 am

"My mom took me to one doctor who said, 'Your kid has got the flu. Come back in one week,'" he said.

"They said, 'Ma'am, we've got good news, and we've got bad news. The good news is your son's gonna live for now. The bad news is, he's got diabetes. He's got to take shots of insulin, and most likely he'll be dead by 25. If not, he'll either be blind or have renal failure,'" he said.

As he grew up in Tallahassee, Florida, Southerland was determined not to let this death sentence stop him. At 6, he was already managing his Type 1 diabetes on his own.

"For me, it was all I ever knew. I knew I had to breathe, I knew I had to eat and I knew I had to check my blood sugar and give myself insulin shots."

His parents stored only healthy food in the house to keep him from making bad choices. But at 12, Southerland disobeyed the rules and ate a candy bar. That decision would change his life.

"I figured OK, I don't want to wait two hours for my insulin to kick in. I do want to eat these candy bars. How can I do it?" he recalled.

So he hopped on his bike and rode through the neighborhood until his legs got tired.

"That was my journey to start riding," he said. "The bike for me was freedom."

The more he exercised, the less insulin he needed, and the easier it was to manage the disease.

"The bike gave me the discipline and motivation I needed to control my diabetes," he added.

The first sporting goal of the organization was to have a team of athletes compete in the Race Across America, a 3,000-mile bike trek through 12 states.

"We lost the race by three minutes," Southerland said. "So we came back the next year a little smarter in how we manage diabetes, a little more experienced in the race, and we set a world record of 5 days, 15 hours and 43 minutes."

To ensure safety, the organization provides a medical team to support riders during a race. Cyclists undergo a stringent testing regime in the three hours leading up to a race. They also use continuous glucose monitoring, which will sound an alarm if their levels get too high or too low.

In 2008, Southerland created a professional team of diabetic cyclists.

"I was supposed to be dead when we started Team Type 1 as a professional cycling team," he said.

But he was far from it. Southerland competed as a professional cyclist for two years until some injuries took him out of the sport.

Now 35, Southerland's goal is to field the first all-diabetic team in the Tour de France by 2021.

"I believe sport can be the unifying point for people with diabetes," he said.

Southerland's other passion is helping diabetic kids in Rwanda get much-needed medical supplies.

"I nearly put our company out of business in 2010 ... because I bought 400 blood glucose monitors, and I took about 40,000 test strips in bike boxes to the Tour of Rwanda," he said.

"We gave them out to the kids there. Their parents were all in tears because their kids have this tool, which is gonna help them live," he added. "It ripped my heart out."

Every year since then, the organization has continued to send supplies to Rwanda.

"I want every kid with diabetes to know that they are the hero. Every person with diabetes to know that their dreams can come true."

Read the rest here:
Cyclist turns a death sentence into a race against diabetes - CNN

Posted in Diabetes | Comments Off on Cyclist turns a death sentence into a race against diabetes – CNN

Smartphone ‘orders’ body to treat diabetes – BBC News

Posted: April 29, 2017 at 3:40 am


BBC News
Smartphone 'orders' body to treat diabetes
BBC News
Scientists have used a smartphone to control the activity of the living cells inside an animal. The fusion of biology and technology was used to control blood sugar levels in mice with diabetes. The idea, described in Science Translational Medicine ...
We Now Have an App That Can Activate Cells That Manage DiabetesFuturism
Smartphone App Enables Wireless Control of Diabetes | GENGenetic Engineering & Biotechnology News
Forget shots diabetes smartphone app tells cells when to produce ...New Atlas
Seeker -Science Daily -IEEE Spectrum
all 17 news articles »

See the rest here:
Smartphone 'orders' body to treat diabetes - BBC News

Posted in Diabetes | Comments Off on Smartphone ‘orders’ body to treat diabetes – BBC News

Type 2 Diabetes May Be Bad for Brain Health – WebMD

Posted: April 29, 2017 at 3:40 am

By Serena Gordon

HealthDay Reporter

THURSDAY, April 27, 2017 (HealthDay News) -- Previous research has linked type 2 diabetes and memory loss. Now, new research may be closing in on some of the reasons why.

The study found that people with type 2 diabetes -- particularly those who are overweight or obese -- have thinner gray matter in several areas of the brain.

These brain regions are related to memory, executive function, movement generation and visual information processing, said the study's senior author, Dr. In Kyoon Lyoo. He's director of the Ewha University Brain Institute in Seoul, South Korea.

"Obesity leads to increased risk of type 2 diabetes, metabolic dysfunction and is also associated with brain alterations independently," Lyoo said. "We aimed to investigate whether overweight/obesity influenced brain structure and cognitive function in individuals with early stage of type 2 diabetes."

The study included: 50 overweight or obese people with type 2 diabetes; 50 normal-weight people with type 2 diabetes, and 50 normal-weight people without diabetes.

The Korean study volunteers were between 30 and 60 years old. Those with diabetes had it for five years or less, and they were attempting lifestyle modifications and/or taking oral medication to lower blood sugar levels. No one was taking insulin.

The normal-weight group with type 2 diabetes had slightly better blood sugar control -- a hemoglobin A1C level of 7 percent. The overweight folks with type 2 diabetes had hemoglobin A1C levels of 7.3 percent.

Hemoglobin A1C is a two- to three- month estimate of average blood sugar levels. The American Diabetes Association generally recommends an A1C of 7 percent or less.

All study participants underwent MRI brain scans and tests to measure memory and thinking skills.

"Cortical thickness was decreased in several regions of the diabetic brains. Further thinning of the temporal lobes found in overweight/obese individuals with type 2 diabetes suggests that these regions are specifically vulnerable to combined effects of obesity and type 2 diabetes," Lyoo said.

He said this study alone cannot tease out whether the effect is from excess weight or diabetes or both. But the study did find that the longer someone had diabetes, the more likely they were to have brain changes.

Lyoo said factors such as insulin resistance, inflammation and poor blood sugar management might bring about the changes.

Memory and thinking skills were decreased in people with diabetes -- regardless of weight -- compared to the normal-weight people without type 2 diabetes, the study found.

Because the study only included an Asian population, Lyoo said it isn't clear if these effects would apply to other populations, such as Americans. He also said it isn't known if these effects occur in people with type 1 diabetes, the less common form of diabetes.

Dr. Sami Saba is an attending physician in neuromuscular medicine and electromyography at Lenox Hill Hospital in New York City.

"The regions most affected were the temporal lobes, which are also most prominently affected in people with Alzheimer's," he said of the research.

"While this was not proven on this study, it does suggest that those with diabetes who are also overweight are at higher risk for developing Alzheimer's-type cognitive impairment than those with diabetes who are not overweight," Saba said.

But, he also noted that a major limitation of this study was the lack of overweight/obese people without diabetes to serve as a comparison group.

The take-home message, said Saba, is that weight control is an "important factor in preserving brain health in these patients." He said it's one more reason to work to prevent weight gain.

Lyoo said good blood-sugar management would probably help slow down or prevent these diabetes- or obesity-related brain changes.

Dr. William Cefalu is the chief scientific, medical and mission officer for the American Diabetes Association.

"The presence of overweight and obesity has been shown in other studies to be associated with early structural changes in the brain, and may contribute to cognitive issues," he said.

But, he said that diabetes may also play a role. Both Lyoo and Cefalu said that more research is needed to figure out which factor is at the root of these changes.

The study was released April 27 in the journal Diabetologia.

WebMD News from HealthDay

SOURCES: In Kyoon Lyoo, M.D., Ph.D., director, Ewha University Brain Institute, Seoul, South Korea; Sami Saba, M.D., attending physician in neuromuscular medicine and electromyography, department of neurology, Lenox Hill Hospital, New York City; William Cefalu, M.D., chief scientific, medical and mission officer, American Diabetes Association; April 27, 2017, Diabetologia

Link:
Type 2 Diabetes May Be Bad for Brain Health - WebMD

Posted in Diabetes | Comments Off on Type 2 Diabetes May Be Bad for Brain Health – WebMD

Milton father runs North Pole half-marathon for diabetic son – Atlanta Journal Constitution

Posted: April 29, 2017 at 3:40 am

Many parents say that they will do anything for their children, but for Doug Wright, that meant going to the top of the world and enduring freezing temperatures.

The 58-year-old stay-at-home dad from Milton wanted to do something to raise awareness for Type 1 diabetes, a disease his 8-year-old son Jake lives with.

Earlier this month, Wright ran a half-marathon in the North Pole. He didnt see Santas Workshop or any polar bears, but Wright raised more than $4,500 for the Juvenile Diabetes Research Foundation.

Going to the North Pole for me was drawing that extreme, Wright said. People ask, Why are you doing that? and I say, Well, because my kid has Type 1 diabetes and I think thats pretty freakin extreme. So, Im going to do what I can to support him.

With nine children coming before Jake, Wright and his wife thought they had seen everything. They knew how to handle all types of illnesses and injuries any kid might get.

Jake started getting sick in Febuary 2016. He was vomiting often, he didnt want to eat and he wasnt getting better.

Wright took his boy to the nearest hospital and after a nurse and doctor saw him they told Wright that his youngest son was in distress and that they couldnt help him. Wright scooped Jake off the table and took him to Children's Healthcare of Atlanta at Scottish Rite Hospital where he got the proper care he needed.

To have that facility here is a blessing to those who live in this area, Wright said. I think if I had to drive another 20 minutes, we wouldve lost Jake. By the time we got there, he was incoherent.

While medical professionals were working on Jake, a doctor stepped away from the table to ask Wright if there was a history of diabetes in the family. Wright said, No. Not at all. Nothing.

Jake had tubes in his arms, his clothes were ripped off, and doctors were trying everything. Finally, a doctor turned to Wright and told him they were going to treat Jake as if he had Type 1 diabetes. And it worked. Jake was stabilized and began getting better.

The doctor started talking about a lot of things, but all I heard him say was that my son was going to live, Wright said. Thats all I wanted to know.

Jake nearly died from diabetic ketoacidosis and was eventually diagnosed with Type 1 diabetes. Then, the in-home care started.

With todays technology, Jake and his family can constantly monitor his blood glucose levels on his iPhone with the use of a device called a Dexcom, an FDA approved device that can be attached to a diabetics body and will send readings using Bluetooth.

Shortly after discovering Jake had diabetes, Wright and his wife began researching the disease and looking at organizations who were raising money for research and awareness. The one they liked the most was JDRF, the Juvenile Diabetes Research Foundation.

Theres no hidden dream or agenda with them, Wright said. They do what they can to help (diabetics) live a normal life. Theres an understanding that, they may never find a cure, but theyre going to make sure (diabetics) wake up in the morning and (live) like the rest of us do.

Doug Wright "dabs" for his son in the North Pole. Submitted

Wright eventually got the feeling that he wanted to do something extreme to show his son he had his back with his extreme disease.

Scrolling through Facebook one day, he saw an ad and article on the North Pole Marathon. Wright said he hadnt ran a race since 1996, but that didnt stop him his mind was made up and he began training.

Wright prepped his body and arrived in the North Pole on April 9 to run a half-marathon. He wore many layers for the race that included more than 50 people from 24 countries. The temperatures dipped down to 40 degrees below zero.

Ten miles into the race, cramps kicked in and Wright found himself on his back in the snow. He was punching the ground in a fit of rage. Eventually, two other runners came along and helped him stretch. Wright was good to go and completed six more miles.

The track of the marathon includes a tent where runners can go in, hydrate, change clothes and warm up. Wright says he changed clothes three times because wearing sweaty clothes can result in hypothermia and he was out on the ice for eight hours. He thinks he did well for someone who hadnt ran a race in 21 years.

And Wright did raise some money for JDRF too. As of April 28, he had raised $4,528.44. Folks who wish to donate to the cause can visit thedonation page.

You dont go to the North Pole to set land-speed records, Wright said. You go there for the experience and a cause. When I heard about the North Pole marathon, I talked to my wife and said, You know, we talk about going to the ends of the Earth for our children. How about we do it?.

Like North Fulton County News Now onFacebook | Follow onTwitterandInstagram

Scientists In Texas Closer To Diabetes Cure With Unconventional Treatment

Follow this link:
Milton father runs North Pole half-marathon for diabetic son - Atlanta Journal Constitution

Posted in Diabetes | Comments Off on Milton father runs North Pole half-marathon for diabetic son – Atlanta Journal Constitution

Meet Curry Cates: 2017 Big Man on Campus – The Auburn Plainsman

Posted: April 28, 2017 at 1:52 am

By Claire Tully | Campus Editor | 14 hours ago Image by Kae Henderson | Photographer | The Auburn Plainsman

Curry Cates, contestant and winner of the 22nd annual Big Man on Campus Pageant on Thursday, April. 13, 2017, in Auburn, Ala.

Zeta Tau Alpha's Gamma Rho chapter on campus hosts the Big Man on Campus event each spring to raise money for breast cancer research in the form of an all-male pageant.

Contestants performed in opening numbers, individual talents, dressed in formal wear and answered on stage questions at the event, in addition to collaborating with the sororities to raise funds prior to the pageant.

This year,Curry Cates, junior in health services administration , was crowned the winner after impressing judges with his performance of "You Raise Me Up" by Josh Groban.

"My entire family can sing," Cates said."My dad, sister, grandparents, so I grew up in church singing and sang in choir in high school."

Cates said singing has been a hobby of his for years, so it made sense he chose to perform a song during the pageant's talent segment.

"During high school I attended Alabama Allstate chorus all 4 years, and I started taking voice lessons," Cates said."I participated in NATS (National Association of Teachers of Singing) competition where I placed 1st in my category senior year. I have always enjoyed singing, and love being able to sing with family and friends."

As for the fundraising portion of the competition, Cates said he worked closely with Tri Delta.

"I partnered with my nominating sorority Tri Delta in raising the funds necessary to support The Zeta Foundation," Cates said.

Prior to competing, Cates participated in other organizations, which have kept him active on Auburn's campus.

"I am a prior CWE counselor and am the Director of Auburn Family for Dance Marathon for this year," Cates said.

Cates said one of the greatest things he's had the opportunity to do is donate stem cells. He said the connection to Auburn occurred when he entered the registry on the concourse one day.

"I would have to say getting the opportunity to donate stem cells to a patient with Acute Myeloginis Leukemia, which was set up through Be The Match, a national bone marrow registry," Cates said."I was able to go to D.C. over Christmas break and donate these potentially life saving stem cells to a patient in France who was around my age. Really great experience."

View post:
Meet Curry Cates: 2017 Big Man on Campus - The Auburn Plainsman

Posted in Alabama Stem Cells | Comments Off on Meet Curry Cates: 2017 Big Man on Campus – The Auburn Plainsman

Bosan for establishing Islamic Biotechnology Centre – Pakistan Observer

Posted: April 28, 2017 at 1:51 am

Staff Reporter

Islamabad

Minister for National Food Security and Research Sikandar Hayat Khan Bosan called for establishing Islamic biotechnology center in order to develop the agriculture and related sectors for the socio-economic prosperity of Muslim countries. Addressing the 3rd International Conference on Agriculture, Food Security and Biotechnology on an other day, he said that government believes that practical collaboration among the Muslim countries in the cutting edge areas of modern biotechnology was the need of time. The event was organized by Pakistan Agricultural Research Council (PARC) in collaboration with COMSATS, Islamic Educational, Scientific and Cultural Organization (ISESCO) and CIMMYT. The aim of the conference was to share the international best practices of using the biotechnology for the development of agriculture sector and food security. The minister termed the exchange of eminent scientist for short term and graduating students among Islamic countries as another good form of cooperation. He called upon the scientists for encouraging and promoting smart agricultural practices to build the resilience in agri-sector. Pakistan was working on the development of infrastructure for using modern and innovative technologies including the biotechnology for uplift of agriculture, health and industrial sectors of the country, he added. Pakistan has improved its crop yield and productivity over the years and it was producing surplus of wheat, maize, potato and sugarcane, he added. He said that scientist and biotechnologist in Pakistan has achieved the diversification in seed development and moved to a higher value added seeds, particularly in the crops sector. The minister said that all the modern techniques should be replicated after tailor-made alterations keeping in view of local settings and environmental factors.

The rest is here:
Bosan for establishing Islamic Biotechnology Centre - Pakistan Observer

Posted in Biotechnology | Comments Off on Bosan for establishing Islamic Biotechnology Centre – Pakistan Observer

Page 1,584«..1020..1,5831,5841,5851,586..1,5901,600..»